BACKGROUND: Intramedullary spinal cord tumors are rare but clinically significant entities. Resection is critical to prevent permanent neurological deficits. However, no studies have investigated the quality of life (QOL) benefit of resection in adults. OBJECTIVE: To investigate QOL outcomes after intramedullary spinal cord tumors resection. METHODS: A consecutive retrospective review of all patients who underwent intramedullary spinal cord tumors resection at a single tertiary care institution between January 2008 and December 2013 was conducted. QOL was measured by the EuroQol 5-Dimensions (EQ-5D), Pain Disability Questionnaire (PDQ), and Patient Health Questionnaire-9 (PHQ-9). Multivariable regression was used to identify independent predictors of outcomes. RESULTS: Among 45 patients, the most common pathology was ependymoma (60%). No significant changes between preoperative and postoperative EQ-5D, PDQ, or PHQ-9 were observed. Improvements exceeding the minimal clinically important difference occurred in 28% of patients in EQ-5D, 28% in PDQ, and 16% in PHQ-9. Worse preoperative neurological status predicted worsened EQ-5D (b = 20.09, P = .04) and PDQ (b = 20.77, P , .01), while ependymomas predicted QOL improvement exceeding the minimal clinically important difference in PDQ (OR 14.98, P = .04) and approached significance in EQ-5D (OR 43.52, P = .06). Conversely, cervical tumors predicted worsened PDQ (b = 18.32, P , .01) and failure to achieve EQ-5D minimal clinically important difference (OR ,0.01, 95% CI ,0.01-0.65, P = .02). Postoperative complications, such as syrinx formation (b = 20.09, P = .04) and cerebrospinal fluid leak (b = 13.85, P = .04), predicted diminished improvement in EQ-5D and PDQ, respectively. CONCLUSION: Although resection did not significantly improve QOL, it is likely necessary to arrest QOL deterioration. Patients with better preoperative neurological status or ependymoma experienced QOL improvement, while postoperative complications negatively impacted long-term QOL.
I
ntramedullary spinal cord tumors (IMSCT) are rare entities, comprising 2% to 4% of central nervous system neoplasms and 20% to 25% of spinal cord tumors. [1] [2] [3] Resection is critical to prevent permanent neurological deficits; moreover, radical resection has been associated with increased overall survival. [4] [5] [6] [7] [8] [9] [10] Although resection poses significant technical challenges, recent advances in neuroimaging, microsurgical techniques, and intraoperative monitoring have permitted safer and more aggressive resections. 6, 7, 9, 11, 12 Despite these advancements, patients may still experience perioperative and long-term morbidity. 8, 10, 13 Several studies have identified pathologic and operative associations with progression-free survival and superior long-term clinical outcomes.
Tumor histology, for example, is well-known to predict feasibility of resection, neurological outcome, and progression-free survival. 7, [14] [15] [16] [17] [18] [19] [20] Other favorable characteristics include better preoperative neurological status, 7, 10, 13, 21, 22 presence of a plane of dissection (POD), 6 achievement of a gross total resection (GTR), [6] [7] [8] 21, 23, 24 and cervical tumors. 8 Conversely, unfavorable outcomes have been associated with thoracic and conus tumors. 10, 13, 25 Although clinical outcomes after IMSCT resection have been extensively described, the literature is limited in reports on the quality of life (QOL) benefit of resection. Outside of a small (n = 10) case series of pediatric patients that demonstrated no QOL benefit compared to controls, 26 no studies have investigated these QOL outcomes. In particular, no data exist for adult patients. These data are critical for predicting and maximizing QOL and for counseling patients with these tumors. In the present study, we sought to characterize QOL outcomes and identify characteristics associated with these outcomes. We hypothesized that resection significantly improves QOL and that patients with ependymomas, better preoperative neurological status, POD, GTR, and cervical tumors experience greater improvements after controlling for confounding characteristics.
METHODS Study Sample
A consecutive retrospective chart review of all adult patients who underwent IMSCT resection at a single tertiary care institution between January 2008 and December 2013 was conducted. Patients were excluded if they had incomplete postoperative QOL data, presented after prior resection at another institution, had metastatic disease or von HippelLindau disease, were under the age of 18 at time of presentation, or underwent biopsy alone.
Clinical, operative, pathologic, and radiologic reports were also reviewed. The Modified McCormick Scale (MMS), a simplified ordinal scale of deteriorating functional status, was applied both preoperatively and at last follow-up. 14, 27 This scale ranges from intact neurologic status to paraplegia or quadriplegia. Preoperative status was further characterized by the presence of motor, sensory, and bladder or bowel dysfunction.
Perioperative data collected from the electronic medical record included number of operative spinal levels, presence or absence of POD, and achievement of GTR. All pathologic diagnoses were confirmed by permanent section analysis. Additionally, perioperative documentation was reviewed for any occurrence of complications, including cerebrospinal fluid (CSF) leak, surgical site infection (SSI), deep vein thrombosis, epidural hematoma, and syrinx formation. Postoperative length of hospital stay and disposition at discharge were similarly recorded.
QOL Outcome Measures
Preoperative and postoperative QOL data were collected via the institutional prospectively collected database of patient-reported health status measures that includes validated questionnaires administered at each outpatient visit. Collected health status measures questionnaires include the EuroQol 5-Dimensions (EQ-5D), [28] [29] [30] Pain Disability Questionnaire (PDQ), 31, 32 and Patient Health Questionnaire-9 (PHQ-9). [33] [34] [35] For all measures except the EQ-5D index, a decrease in value represents improvement. These questionnaires were prospectively collected, both preoperatively and at each postoperative follow-up visit. The EQ-5D contains 5 dimensions of a patient's health state: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is scored from 1 to 3; for example, for the anxiety/depression dimension, patients check a box indicating that they are (1) "not anxious or depressed," (2) "moderately anxious or depressed," or (3) "extremely anxious or depressed." An EQ-5D index is derived from the 5 subscores and represents the patient's quality-adjusted life-years, ranging from 0 (death) to 1 (perfect health). The minimum clinically important difference (MCID) for the EQ-5D index after spine surgery has been reported to be 0.1.
36,37
The PDQ evaluates chronic disabling musculoskeletal and spinal disorders, focusing on disability and patients' abilities to perform activities of daily living. It records functional and psychosocial components of pain as a total score between 0 and 150. The MCID for the PDQ has been reported to be 20.
38
The PHQ-9 assesses for depression based on the 9 criteria established in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, for major depressive disorder. Each of the 9 questions is scored from 0 ("not at all") to 3 ("nearly every day") for a total score that ranges from 0 to 27. The diagnostic validity of the PHQ-9 has been established in large multicenter analyses. 34, 35 The MCID for the PHQ-9 has been reported to be 5. 39 
Statistical Analyses
Collected data were analyzed using the JMP Pro 10 statistical software package (SAS Institute Inc., Carey, North Carolina). 40 Continuous data were expressed as a mean 6 standard deviation or median with interquartile range; paired data were compared via paired t tests.
Regression analysis was performed to control for confounding characteristics and to identify independent predictors of QOL outcomes. In order to avoid overfitting, only variables demonstrating association (P , .20 via simple regression) with QOL changes were analyzed via multivariable regression. Two sets of models were utilized with the following outcome variables: (1) absolute change in EQ-5D/PDQ/ PHQ-9 (postoperative minus preoperative); and (2) improvement in EQ-5D/PDQ/PHQ-9 exceeding the MCID. For each model, preoperative QOL measures were included to adjust for the ceiling effect and to normalize all changes to baseline scores. All independent variables were tested for collinearity (R 2 $ 0.8), with no evidence observed. Regression coefficients (b) were reported for the first set of models, while odds ratios were reported for the second set of models; P , .05 was considered statistically significant.
RESULTS

Patient and Operative Characteristics
During the 6-year inclusion period, 48 patients underwent resection. Among these, 3 patients (6%) were excluded, as they were lost to follow-up without postoperative quality of life measures. Forty-five patients were included and followed for a median of 22 months postoperatively (Table 1) . Median age was 49 years, and 60% of patients were male. IMSCT were characterized by location as cervical (33%), cervicothoracic (18%), thoracic (40%), or conus (9%). No patients received prior radiation therapy or chemotherapy. Presenting symptoms included sensory deficit (93%), motor weakness (64%), and bladder or bowel dysfunction (33%). The majority of patients were classified preoperatively as MMS grade II (62%), followed by grade III (20%) and grades I and IV (9% each).
The median number of operative vertebral levels was 2 ( Table 2 ). POD and GTR were each achieved in 69% of patients. The most common tumor pathologies were ependymoma (60%) followed by hemangioblastoma (13%), astrocytoma (10%), and cavernoma (7%). Postoperative SSI (16%) and syrinx formation (16%) were the most common complications. MMS grade II remained the most common postoperatively (51%), with a greater proportion of grade III (27%) and grade V (4%) patients. Fifty-one percent of patients experienced better follow-up neurological status, while 27% were worse and 22% remained unchanged. The median length of hospital stay was 5 days, with 42% of patients returning home after discharge and 58% entering rehabilitation.
QOL Outcomes
No significant changes in QOL were observed after resection in the pooled cohort (Table 3) . When comparing preoperative to postoperative QOL at last follow-up, no differences were observed in EQ-5D index (0.627 vs 0.608, P = .73) or its 5 dimensions. Similarly, no differences were observed between preoperative and postoperative QOL in total PDQ (72.10 vs 74.73, P = .76) or PHQ-9 (7.76 vs 7.11, P = .60). However, QOL improvements exceeding the MCID were observed in the EQ-5D (28% of patients), PDQ (28%), and PHQ-9 (16%).
QOL Improvement Multivariable Regression Analysis
Multivariable regression was performed to identify significant independent predictors of absolute change in EQ-5D, PDQ, and PHQ-9 (Table 4) . Four variables were identified as predictors of change in EQ-5D index (P , .05): preoperative EQ-5D, preoperative MMS, postoperative syrinx formation, and followup neurological status. Improvement in EQ-5D was associated with improved follow-up neurological status (b = 0.13, P = .01). In contrast, greater preoperative MMS (b = 20.09, P = .04), postoperative syrinx formation (b = 20.09, P = .04), and worsened follow-up neurological status (b = 20.04, P = .01) were associated with worsened EQ-5D. Finally, longer duration of follow-up trended towards predicting EQ-5D improvement (b , 0.01, P = .06).
Multivariable regression revealed 6 variables as predictors of change in PDQ: preoperative PDQ, preoperative MMS, age, postoperative CSF leak, follow-up neurological status, and tumor location. Improvement in PDQ was associated with improved follow-up neurological status (b = 217.50, P = .02) and thoracic tumors (b = 211.93, P , .01). Conversely, greater preoperative MMS (b = 20.77, P , .01), greater age (b = 0.69, P = .02), postoperative CSF leak (b = 13.85, P = .04), worsened follow-up neurological status (b = 12.33, P = .02), and cervical (b = 18.32, P , .01) and cervicothoracic (b = 11.10, P , .01) tumors were associated with worsened PDQ. Two variables were found to be predictors of change in PHQ-9: preoperative PHQ-9 and length of hospital stay, with longer length of hospital stay (b = 0.36, P = .04) predicting worsened PHQ-9.
MCID Multivariable Regression Analysis
Additional multivariable regression was performed to assess for significant independent predictors of improvement in EQ-5D, PDQ, and PHQ-9 exceeding the MCID (Table 5) . Five variables were identified as predictors of improvement exceeding the EQ-5D MCID: preoperative EQ-5D, preoperative MMS, tumor location, tumor pathology, and length of hospital stay. Ependymomas trended towards significance in predicting improvement exceeding the MCID (OR 43.52, 95% CI 0.84-200.90, P = .06). Conversely, greater preoperative MMS (OR 0.09, 95% CI ,0.01-0.76, P = .02) and cervical tumors (OR ,0.01, 95% CI ,0.01-0.65, P = .02) were associated with failure to achieve an EQ-5D MCID.
Multivariable regression identified 2 variables to be predictors of improvement in PDQ exceeding the MCID: preoperative PDQ and tumor pathology. Specifically, ependymomas were associated with improvement in PDQ exceeding the MCID (OR 14.98, 95% CI 1.13-687.19, P = .04). No significant independent predictors of PHQ-9 improvement exceeding the MCID were identified. 
DISCUSSION
In the present study, we sought to characterize QOL outcomes after resection of adult IMSCT. While resection is necessary for preventing progressive neurologic decline, QOL may not necessarily correlate with clinical status. We hypothesized that resection results in significant QOL benefit, with more favorable outcomes among those with better preoperative neurological status, POD, GTR, and cervical tumors. We observed that pooled QOL does not necessarily improve after resection; however, certain patients with favorable clinical and pathologic characteristics may be expected to achieve a clinically relevant QOL improvement. These results may permit proper counseling regarding the longterm QOL benefit of resection, and identify those who require greater perioperative and long-term attention with regard to pain and depression.
Clinical Outcomes After Resection of Intramedullary Spinal Cord Tumors
Several studies have investigated clinical and functional outcomes after IMSCT resection. Resection of ependymomas, for example, provides significant neurological and symptomatic benefit. Hanbali et al 22 reported the outcomes of 26 patients after resection of ependymomas during a 21-year period. They observed that preoperative neurological deficits began to improve by 1 month postoperatively, and that continued improvement persisted for up to 1 year. Aghakhani et al 41 later reported clinical outcomes for 82 consecutive adult patients with ependymomas during a 15-year period. Among patients who did not have preoperative neurological deficits, resection was followed by symptomatic resolution in 30% of patients, stabilization in 60% of patients, and deterioration in 10% of patients.
Although resection of ependymomas has generally yielded favorable clinical outcomes, astrocytomas present a greater challenge. McGirt et al 42 reported 35 cases of malignant astrocytoma during the course of 12 years. Increased overall survival was observed after resection of non-disseminated anaplastic astrocytomas; however, a combination of surgery with radiotherapy to treat glioblastoma multiforme resulted in no difference in survival compared with historical controls of diagnostic biopsy and radiotherapy. [43] [44] [45] [46] 
XIAO ET AL
Many studies have investigated pathologic and operative characteristics associated with progression-free survival and long-term neurological outcomes after IMSCT resection. These characteristics include better preoperative neurological status, 7,10,13,21,22 presence of POD, 6 achievement of GTR, [6] [7] [8] 21, 23, 24 and cervical tumors. 8 Garcés-Ambrossi et al 6 reported 101 consecutive cases during a 7-year period and found that achievement of GTR was likely to increase progression-free survival in patients with ependymomas and hemangioblastomas, but not in those with gliomas. Furthermore, presence of POD improved outcomes for all patients. Karikari et al 15 later studied 102 patients with ependymomas and gliomas during an 11-year period. Similar to previous studies, progression-free survival was associated with preoperative neurological status, tumor histology, and extent of resection. More recently, Klekamp 8 reviewed 225 patients during a 23-year period and found that GTR was associated with decreased long-term morbidity. Cervical tumors were similarly associated with decreased morbidity, possibly as a consequence of more frequent GTR. Finally, better preoperative neurological status and increased surgeon experience were predictive of decreased morbidity.
In the present study, we observed relatively high rates of postoperative complications, including SSI (16%), syrinx formation (16%), CSF leak (11%), and deep venous thrombosis (11%). Among these complications, we observed significant overlap between SSI and CSF leak, with 43% of patients experiencing SSI also having CSF leak. Several of these complications may be attributed to the technical challenges of IMSCT resection and highlight the importance of infection prevention protocols and frequent postoperative monitoring.
QOL Outcomes After Resection of Intramedullary Spinal Cord Tumors
Despite the number of investigations reporting clinical outcomes after IMSCT resection, there remains a clear gap in the literature regarding QOL outcomes after resection. Schneider et al 26 recently reported a case series on the QOL of 10 pediatric patients who had undergone surgery for IMSCT. When comparing this small cohort to a control group from the normal sample population, they found no differences in Pediatric Quality of Life Questionnaire version 4 scores. Thus, although it seems reasonable to expect improvements in QOL to parallel clinical QOL AFTER ADULT IMSCT RESECTION outcomes, our results suggest that QOL does not necessarily significantly improve after resection in a pooled cohort. Specifically, no significant differences in QOL were observed at last follow-up as measured by the EQ-5D, PDQ, or PHQ-9 (Table 3) . These results suggest that resection is likely necessary to arrest progressive QOL deterioration in patients with IMSCT; however, patients who experience QOL decline as a consequence of their disease may not recover. However, there exists a subset of patients who enjoy a clinically relevant QOL improvement, as evidenced by the patients achieving an MCID in EQ-5D (28%), PDQ (28%), and PHQ-9 (16%). Notably, these results are similar to the aforementioned findings of Aghakhani et al, 41 who observed symptomatic resolution in only 30% of patients. It is worth noting, however, that Aghakhani et al reported only cases of ependymomas, the pathology associated with the most favorable clinical outcomes.
Predictors of QOL Improvement
Several studies have identified pathologic and operative features associated with superior clinical outcomes after IMSCT resection. In particular, better preoperative neurological status, presence of POD, achievement of GTR, ependymomas, and cervical tumors have been associated with favorable clinical outcomes, while cervicothoracic and thoracic tumors have been associated with poorer outcomes. In the present study, we identified certain consistencies with these previously identified features (Tables 4 and 5 ). Specifically, better preoperative neurological status and ependymomas were both independently associated with improvement in QOL. Preoperative neurological status was strongly associated with absolute improvement in EQ-5D and PDQ, as well as EQ-5D exceeding the MCID, demonstrating that preoperative neurologic status correlates with not only clinical outcomes, but also long-term QOL outcomes. Similarly, ependymomas were found to be predictive of achieving a PDQ MCID and trended towards significance in predicting an EQ-5D MCID. This is consistent with previous observations that resection of ependymomas typically results in the most favorable clinical outcomes.
Certain observations of the present study differ from those reported in the literature. Specifically, cervical and cervicothoracic tumors were observed to be associated with worsened PDQ and failure to achieve an EQ-5D MCID. This differs from observations of Klekamp, 8 who identified a greater rate of postoperative morbidity among thoracic and conus tumors. The more robust vascular supply of the cervical spinal cord has been hypothesized to be responsible for favorable clinical outcomes, while the limited blood supply of the thoracic cord and the neurologic significance of the conus have been linked with poorer outcomes. However, these anatomic and physiologic considerations may oversimplify the differences between cervical, thoracic, and conus tumors. Klekamp, for example, noted that rostral tumors were associated with an elevated incidence of postoperative neuropathic pain syndromes. This finding precisely supports the findings of the present study; namely, cervical and cervicothoracic tumors were associated with worsened PDQ postoperatively. Furthermore, Karikari et al 15 found no association between postoperative morbidity and spinal level. As such, the relationship between tumor location and clinical or QOL outcomes is likely complex, with factors such as POD, vascular supply, operative positioning, surgical technique, and postoperative rehabilitation affecting and confounding this relationship. 8 In the present study, POD and achievement of GTR were hypothesized to predict QOL improvement, but neither were identified as such after multivariable regression. Clinically, increased resection has been identified in the literature as predictive of superior outcomes. 6 It is possible, however, that this clinical benefit does not translate to QOL, or may reflect our more general observation that resection typically stabilizes but does not necessarily improve QOL.
Finally, beyond investigating previously identified pathologic and operative features associated with clinical outcomes, the present study also identified several additional independent predictors of QOL outcomes. Postoperative syrinx formation and CSF leak, worsened follow-up neurological status, advanced age, and greater length of hospital stay were all significant independent predictors of diminished QOL outcomes after resection. It is significant to note that acute and transient postoperative complications such as CSF leak, syrinx formation, and extended hospital stay may impact long-term QOL. As such, surgeons must remain cognizant of these complications and enact measures for reducing postoperative morbidity, especially in the context of such rare procedures. Furthermore, it is important to consider that postoperative worsening of neurologic status correlates with QOL decline. This emphasizes the relationship between neurologic function and QOL, as well as the opportunity to minimize neurological and QOL deterioration via intraoperative techniques such as neurophysiological monitoring.
11,12
Limitations
The present study has several limitations. Although most investigations include cases spanning multiple decades, the present study provides a more concise and contemporary timeframe (2008-2013) reflective of modern surgical techniques and technology. However, this contributes to the limitations of the study. Because of the rare nature of IMSCT, the sample size was smaller than some larger historical series of IMSCT. Furthermore, the included patients were heterogeneous with respect to tumor pathology. As such, we lacked the power necessary to conduct more robust statistical analyses, such as determining the effects of histology beyond ependymoma on QOL outcomes. Furthermore, it is possible that the present study lacked the power to identify predictive characteristics such as POD and GTR. Moreover, because this series was limited to a single tertiary care institution, the generalizability of the results is limited to centers with similar populations.
This study was retrospective in nature and therefore subject to selection and measurement biases. However, given the rarity of these tumors, it is exceedingly challenging to conduct fully prospective investigations. The present study is significant in that QOL data were collected in a standardized and prospective fashion.
Finally, as with any QOL study, it is important to recognize that QOL data are subject to significant daily variation and are susceptible to patients' emotional statuses, interactions with healthcare staff, and preoperative expectations for symptomatic relief. Variations in preoperative QOL impact postoperative QOL changes; as such, preoperative QOL measures were incorporated into the model to account for this ceiling effect.
CONCLUSION
Although many studies have reported clinical outcomes after IMSCT resection, there remains a clear gap in the literature regarding the QOL benefit of resection. The present study is the first to characterize these QOL outcomes and identify predictive characteristics for long-term QOL improvement in adults. While resection did not significantly improve pooled QOL, it is likely necessary to arrest progressive QOL deterioration. Additionally, certain patients with favorable clinical and pathologic characteristics may achieve clinically relevant QOL improvements. Specifically, patients with better preoperative neurologic status and ependymoma pathology, among other characteristics, experienced significant improvement in EQ-5D and PDQ. In contrast, postoperative complications such as CSF leak, syrinx formation, and worsened postoperative neurologic status negatively impact long-term QOL.
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